drugset / Trial / NCT00960726
NOV-002 in Myelodysplastic Syndrome (MDS)
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if NOV-002 can help to restore bone marrow and blood levels in patients who have MDS. The safety of this drug will also be studied.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Outcome
Outcome not reported
Stopped: “Study withdrawn at sponsor request.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NOV-002 | Unknown | 60 mg | Subcutaneous |